| Product Code: ETC7650208 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Drug-Device Combination Products Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Drug-Device Combination Products Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Israel Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Israel Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Israel Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel leading to a higher demand for advanced treatment options. |
4.2.2 Technological advancements in drug-device combination products, enhancing their efficacy and safety. |
4.2.3 Favorable regulatory environment promoting innovation and development in the market. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of drug-device combination products, leading to delays in market entry. |
4.3.2 High development costs and lengthy approval processes impacting the product launch timelines. |
4.3.3 Limited reimbursement policies for innovative drug-device combination products, hindering market penetration. |
5 Israel Drug-Device Combination Products Market Trends |
6 Israel Drug-Device Combination Products Market, By Types |
6.1 Israel Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Drug-Device Combination Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2021- 2031F |
6.1.4 Israel Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2021- 2031F |
6.1.5 Israel Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2021- 2031F |
6.1.6 Israel Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2021- 2031F |
6.1.7 Israel Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2021- 2031F |
6.1.8 Israel Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2021- 2031F |
6.1.9 Israel Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.1.10 Israel Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.2 Israel Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F |
6.2.3 Israel Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.2.4 Israel Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2021- 2031F |
6.2.5 Israel Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2021- 2031F |
6.2.6 Israel Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2021- 2031F |
6.2.7 Israel Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Israel Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Israel Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2021- 2031F |
6.3.3 Israel Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2021- 2031F |
6.3.4 Israel Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2021- 2031F |
6.3.5 Israel Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
7 Israel Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Israel Drug-Device Combination Products Market Export to Major Countries |
7.2 Israel Drug-Device Combination Products Market Imports from Major Countries |
8 Israel Drug-Device Combination Products Market Key Performance Indicators |
8.1 Adoption rate of drug-device combination products by healthcare providers in Israel. |
8.2 Number of successful clinical trials and regulatory approvals for new drug-device combination products. |
8.3 Investment trends in research and development within the Israel drug-device combination products market. |
9 Israel Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Israel Drug-Device Combination Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Drug-Device Combination Products Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Drug-Device Combination Products Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Israel Drug-Device Combination Products Market - Competitive Landscape |
10.1 Israel Drug-Device Combination Products Market Revenue Share, By Companies, 2024 |
10.2 Israel Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here